Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897494 · ClinicalTrials.gov registry record
Identification of Biomarkers for Early Detection of Pancreatic Cancer
A clinical trial, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- 75
- Enrollment target
NCT00897494: Completed study, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT00897494 is a clinical trial that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897494 has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is examining blood samples from patients with cancer to identify biomarkers that may help in the early detection of pancreatic cancer.
Interventions
- GENETIC protein expression analysis
- OTHER laboratory biomarker analysis
- OTHER mass spectrometry
- OTHER surface-enhanced laser desorption/ionization-time of flight mass spectrometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2005-02 |
| Est. Completion | 2011-04 |
What the finished NCT00897494 record still lists
NCT00897494 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which protein expression analysis is the first listed.
NCT00897494 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897494 about?
NCT00897494 is a clinical study titled "Identification of Biomarkers for Early Detection of Pancreatic Cancer". RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is examining blood samples from patients with cancer to identify biomarkers that...
What is the current status of trial NCT00897494?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2005-02. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00897494?
The interventions under investigation include: protein expression analysis (GENETIC), laboratory biomarker analysis (OTHER), mass spectrometry (OTHER), surface-enhanced laser desorption/ionization-time of flight mass spectrometry (OTHER).
Who is sponsoring clinical trial NCT00897494?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia